US 11897874
Compounds and methods for modulating Interleukin-2-inducible T-cell kinase
granted A61PA61P35/00A61P43/00
Quick answer
US patent 11897874 (Compounds and methods for modulating Interleukin-2-inducible T-cell kinase) held by Corvus Pharmaceuticals, Inc. expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corvus Pharmaceuticals, Inc.
- Grant date
- Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P35/00, A61P43/00